Drug Profile
F 15845
Alternative Names: 15845; F15845Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pierre Fabre
- Class Ischaemic heart disorder therapies
- Mechanism of Action NAV1.5 voltage-gated sodium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Ischaemic-heart-disorders in France
- 23 Oct 2008 Profile reviewed for AstraZeneca client query: chemical structure and drug classes to be added
- 31 Dec 2007 Phase-I clinical trials in Ischaemic heart disorders in France (unspecified route)